Literature DB >> 21288322

Malignant fibrous histiocytoma originating from the mesorectum: a case report.

Yoshifumi Nakayama1, Noritaka Minagawa, Takayuki Torigoe, Koji Yamaguchi.   

Abstract

BACKGROUND: Malignant fibrous histiocytoma (MFH) is a common sarcoma affecting soft tissues of the body, especially of the extremities or trunk. Prognosis of the abdominal MFH is usually poor. CASE
PRESENTATION: A 52-year-old female presented to our surgical outpatient clinic with a lower abdominal tumor that had been gradually increasing in size. Clinical examination revealed a firm, irregularly surfaced, fixed, painless, child-head-sized tumor located in her lower abdomen. Computed tomography (CT) and magnetic resonance imaging (MRI) of the abdomen revealed a polycystic tumor at the lower abdomen which was 15 × 13 × 11 cm in diameter and encased the colorectum to the left back side. A barium enema and a colonoscopy showed direct invasion to the rectum. In 2001, the tumor had been excised along with a low anterior resection of the rectum because of direct invasion. The origin of this tumor was the mesorectum. The weight of the excised tumor was 1,500 g, including 800 ml of a brown fluid. A histopathological diagnosis revealed a common type of MFH, in which mitotic figures are frequently seen.
CONCLUSION: This patient has survived without recurrence, for approximately 8 years since the completed tumor resection. It is important to obtain a complete resection during the MFH treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21288322      PMCID: PMC3038968          DOI: 10.1186/1477-7819-9-15

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  15 in total

1.  MALIGNANT FIBROUS XANTHOMAS.

Authors:  J E O'BRIEN; A P STOUT
Journal:  Cancer       Date:  1964-11       Impact factor: 6.860

2.  Malignant fibrous histiocytoma of the mesentery: report of two cases and review of the literature.

Authors:  L Basso; M Codacci Pisanelli; A Bovino; F Vietri; G D'Ermo; G De Toma
Journal:  G Chir       Date:  2005 Jan-Feb

3.  Retroperitoneal malignant fibrous histiocytoma causing variegated colonic lesions.

Authors:  S Kobayashi; K Goto; S Shiraki; Y Okayama; H Ando; F Okumura; S Nakamura; T Hattsutori; T Joh; M Itoh
Journal:  Intern Med       Date:  1998-04       Impact factor: 1.271

Review 4.  Sonographic findings of malignant fibrous histiocytoma of the mesentery-report of two cases.

Authors:  T Shibuya; H Ishida; K Konno; T Komatsuda; Y Hamashima; M Sato; O Masamune
Journal:  Eur J Ultrasound       Date:  1998-12

5.  Malignant fibrous histiocytoma: a retrospective study of 167 cases.

Authors:  M M Kearney; E H Soule; J C Ivins
Journal:  Cancer       Date:  1980-01-01       Impact factor: 6.860

6.  Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.

Authors:  Joan Maurel; Antonio López-Pousa; Ramón de Las Peñas; Joaquín Fra; Javier Martín; Josefina Cruz; Antonio Casado; Andrés Poveda; Javier Martínez-Trufero; Carmen Balañá; María Auxiliadora Gómez; Ricardo Cubedo; Oscar Gallego; Belen Rubio-Viqueira; Jordi Rubió; Raquel Andrés; Isabel Sevilla; Juan Jose de la Cruz; Xavier García Del Muro; Jose María Buesa
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

7.  Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.

Authors:  Vasilios Karavasilis; Beatrice M Seddon; Susan Ashley; Omar Al-Muderis; Cyril Fisher; Ian Judson
Journal:  Cancer       Date:  2008-04-01       Impact factor: 6.860

8.  Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).

Authors:  Stefan Sleijfer; Monia Ouali; Martine van Glabbeke; Anders Krarup-Hansen; Sjoerd Rodenhuis; Axel Le Cesne; Pancras C W Hogendoorn; Jaap Verweij; Jean-Yves Blay
Journal:  Eur J Cancer       Date:  2010-01       Impact factor: 9.162

9.  Prognostic factors in 227 patients with malignant fibrous histiocytoma.

Authors:  C M Pezzi; M S Rawlings; J J Esgro; R E Pollock; M M Romsdahl
Journal:  Cancer       Date:  1992-04-15       Impact factor: 6.860

10.  Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.

Authors:  Paul Lorigan; Jaap Verweij; Zsuzsa Papai; Sjoerd Rodenhuis; Axel Le Cesne; Michael G Leahy; John A Radford; Martine M Van Glabbeke; Anne Kirkpatrick; Pancras C W Hogendoorn; Jean-Yves Blay
Journal:  J Clin Oncol       Date:  2007-07-20       Impact factor: 44.544

View more
  3 in total

1.  Soft tissue tumors of the anorectum: rare, complex and misunderstood.

Authors:  Mohammed O Nassif; Nora H Trabulsi; Kelli M Bullard Dunn; Ayoub Nahal; Ari-Nareg Meguerditchian
Journal:  J Gastrointest Oncol       Date:  2013-03

Review 2.  Rectum sarcoma: challenging diagnostic and therapeutic modalities.

Authors:  Aikaterini Mastoraki; Dionysios Psarras; Sotiria Mastoraki; Pantelis Vassiliu; Nikolaos Danias; Vasilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  J Gastrointest Cancer       Date:  2013-09

3.  Case Report of Four Different Primary Mesenteric Neoplasms and Review of Literature.

Authors:  Yusuf Yagmur; Sami Akbulut; Serdar Gumus; Mehmet Babur; Mehmet Ali Can
Journal:  Iran Red Crescent Med J       Date:  2016-06-21       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.